+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Multiplex Assays Market, By Product (Reagents & Consumables, Accessories & Instruments, Software & Services), By Type (Nucleic Acid, Protein, Cell-based), By Technology, By Application, By End User, By Region, forecast & opportunities, 2026

  • PDF Icon

    Report

  • 114 Pages
  • October 2021
  • Region: Global
  • TechSci Research
  • ID: 5457880
UP TO OFF until Dec 31st 2022
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

Global multiplex assays market is expected to undergo substantial rate of growth during the forecast period owing to technological advancements in healthcare sector, especially rapid development in nano technology. Increasing prevalence of chronic diseases including cancer, where multiplex assays are significantly used, is also a major driving factor for the growth of this market. Additionally, various benefits of multiplex assays over singleplex and other traditional diagnostics is also anticipated to fuel the growth of multiplex market in the years to come.

Multiplex assay is a type of assay which measures multiple analytes in a single cycle. They are widely used in functional genomics to determine the effects of experimental treatments. A multiplex assay detects proteins and other biomolecules in a biological sample.

Global multiplex assays market can be segmented based on product, type, technology, application, end user and region. Based on technology, the market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR and others. The flow cytometry segment is expected to undergo significant growth during the forecast period as it works on the basis of bead population, which is helpful in computing specific antibody levels in biological fluids.

Region wise, North America is expected to dominate the global multiplex assays market by 2026 owing to regions’ advanced healthcare system and availability of trained professionals. Various governments in the region are also supporting the development of advanced technologies for diagnostics, which is giving a major boost to multiplex assay companies.

Major companies operating in global multiplex assays market include Thermo Fisher Scientific Inc, Luminex Corporation, Illumina Inc, Qiagen N.V., Bio Rad Laboratories Inc, Abcam Plc, Agilent Technologies, Merck Sharp & Dohme Corp, Randox Laboratories Ltd, Meso Scale Diagnostics LLC, Seegene Inc., Becton, Dickinson and Company, Quansys Biosciences, Olink, Bio-Techne, Johnson & Johnson Services, Inc. and Hoffmann-La Roche Ltd, among others. Prominent market players are extensively undergoing research and development activities in order to introduce superior quality assays in the market.

Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze and forecast the market size of global multiplex assays market.
  • To forecast global multiplex assays market based on product, type, technology, application, end user, company and regional distribution.
  • To identify drivers and challenges for global multiplex assays market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global multiplex assays market.
  • To identify and analyze the profile of leading players operating in the global multiplex assays market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of multiplex assays manufacturing companies across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the companies which could not be identified due to the limitations of secondary research.

The publisher calculated global multiplex assays market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used.

Key Target Audience:

  • Multiplex assays manufacturers, vendors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to multiplex assays
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as multiplex assays manufacturing companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:


In this report, global multiplex assays market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Multiplex Assays Market, By Product

  • Reagents & Consumables
  • Accessories & Instruments
  • Software & Services

Global Multiplex Assays Market, By Type

  • Nucleic Acid
  • Protein
  • Cell-based

Global Multiplex Assays Market, By Technology

  • Flow Cytometry
  • Fluorescence Detection
  • Luminescence
  • Multiplex Real-Time PCR
  • Others

Global Multiplex Assays Market, By Application

  • Research & Development
  • Drug Development
  • Biomarker Discovery & Validation
  • Clinical Diagnosis
  • Infectious Disease
  • Cancer
  • Cardiovascular Disease
  • Autoimmune Disease
  • Nervous System Disorders
  • Others

Global Multiplex Assays Market, By End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Research Institutes
  • Reference Laboratories
  • Others

Global Multiplex Assays Market, By Region

  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • North America
  • United States
  • Mexico
  • Canada
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape


Company Profiles: Detailed analysis of the major companies present in global multiplex assays market.

Available Customizations:


With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Multiplex Assays Market4. Executive Summary5. Voice of Customer
6. Global Multiplex Assays Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
6.2.2. By Type (Nucleic Acid, Protein, Cell-based)
6.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
6.2.4. By Application (Research & Development v/s Clinical Diagnostics)
6.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
6.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
6.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
6.2.6. By Company (2021)
6.2.7. By Region
6.3. Product Market Map
7. Asia-Pacific Multiplex Assays Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
7.2.2. By Type (Nucleic Acid, Protein, Cell-based)
7.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
7.2.4. By Application (Research & Development v/s Clinical Diagnostics)
7.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
7.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
7.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
7.2.6. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Multiplex Assays Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Type
7.3.1.2.3. By Technology
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. India Multiplex Assays Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Type
7.3.2.2.3. By Technology
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. Japan Multiplex Assays Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Type
7.3.3.2.3. By Technology
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. South Korea Multiplex Assays Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Type
7.3.4.2.3. By Technology
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Australia Multiplex Assays Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Type
7.3.5.2.3. By Technology
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Europe Multiplex Assays Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
8.2.2. By Type (Nucleic Acid, Protein, Cell-based)
8.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
8.2.4. By Application (Research & Development v/s Clinical Diagnostics)
8.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
8.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
8.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. France Multiplex Assays Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Type
8.3.1.2.3. By Technology
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. Germany Multiplex Assays Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Type
8.3.2.2.3. By Technology
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. United Kingdom Multiplex Assays Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Type
8.3.3.2.3. By Technology
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. Italy Multiplex Assays Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Type
8.3.4.2.3. By Technology
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Spain Multiplex Assays Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Type
8.3.5.2.3. By Technology
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. North America Multiplex Assays Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
9.2.2. By Type (Nucleic Acid, Protein, Cell-based)
9.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
9.2.4. By Application (Research & Development v/s Clinical Diagnostics)
9.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
9.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
9.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
9.2.6. By Country
9.3. North America: Country Analysis
9.3.1. United States Multiplex Assays Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Type
9.3.1.2.3. By Technology
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Mexico Multiplex Assays Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Type
9.3.2.2.3. By Technology
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Canada Multiplex Assays Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Type
9.3.3.2.3. By Technology
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. South America Multiplex Assays Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
10.2.2. By Type (Nucleic Acid, Protein, Cell-based)
10.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
10.2.4. By Application (Research & Development v/s Clinical Diagnostics)
10.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
10.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
10.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Multiplex Assays Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Type
10.3.1.2.3. By Technology
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Colombia Multiplex Assays Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Type
10.3.2.2.3. By Technology
10.3.2.2.4. By Application
10.3.2.2.5. By End User
11. Middle East and Africa Multiplex Assays Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
11.2.2. By Type (Nucleic Acid, Protein, Cell-based)
11.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
11.2.4. By Application (Research & Development v/s Clinical Diagnostics)
11.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
11.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
11.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Multiplex Assays Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Type
11.3.1.2.3. By Technology
11.3.1.2.4. By Application
11.3.1.2.5. By End User
11.3.2. Saudi Arabia Multiplex Assays Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Type
11.3.2.2.3. By Technology
11.3.2.2.4. By Application
11.3.2.2.5. By End User
11.3.3. UAE Multiplex Assays Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Type
11.3.3.2.3. By Technology
11.3.3.2.4. By Application
11.3.3.2.5. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Abbott Laboratories, Inc.
14.2.2. Thermo Fisher Scientific, Inc.
14.2.3. Danaher Corporation
14.2.4. F. Hoffmann-La Roche AG
14.2.5. Siemens Healthineers AG
14.2.6. Bio-Rad Laboratories, Inc.
14.2.7. bioMérieux SA
14.2.8. BÜHLMANN Laboratories AG
14.2.9. Sekisui Medical Co., Ltd.
14.2.10. Randox Laboratories Ltd.
15. Strategic Recommendations16. About the Publisher & Disclaimer

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • BÜHLMANN Laboratories AG
  • Sekisui Medical Co., Ltd.
  • Randox Laboratories Ltd.